Dr. Shuchi Md Anand, MD

Dr. Anand practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Anand's NPI, 1932238326, was assigned on March 3, 2007. Dr. Anand graduated from WashU Medicine in 2006. Dr. Anand holds California license A111707.

Dr. Anand's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Anand's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Anand is also affiliated with UC Davis Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Anand to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account. Dr. Anand's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anand practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Anand's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Anand is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Anand's licenses on file in 3 states: California, Massachusetts and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and kidney disease among the conditions Dr. Anand treats.

CMS data shows 348 Medicare services from Dr. Anand across 8 procedure codes in 2024, for 178 Medicare patients. Medicare paid $37,976 for them.

CMS counts 178 Medicare patients who saw Dr. Anand in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anand's median patient age at 62, with 44% women.

In 2024, Dr. Anand wrote 371 Medicare Part D claims for 74 patients. 80% of them were for generic drugs. CMS names the drug for 234 of them, across 12 drugs with 11 or more claims each, at $286,816 in total drug cost. In 2023, CMS named 208 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Anand for performance year 2024, reported as part of a group. Dr. Anand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anand as offering telehealth.

Dmand AI links 94 papers to Dr. Anand, published from 2008 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Renal Insufficiency, Chronic, Renal Dialysis and Kidney Failure, Chronic. Dr. Anand has published most often in Kidney Int Rep. Dr. Anand's most frequent co-authors are Glenn Matthew Chertow, MD, Julie Parsonnet, MD and Geoffrey Allan Block, MD.

Dmand AI links Dr. Anand to 2 clinical trials. Conditions studied include Heart Failure, Kidney Failure, Chronic and Heart Diseases. Stanford University sponsors the most, 2.

CMS Open Payments shows 9 general payments to Dr. Anand from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Travere Therapeutics, Inc. paid the most, $4,864.

Dr. Anand graduated from WashU Medicine in 2006.

Dr. Anand is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.